SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerguson Regulatory News (FERG)

Share Price Information for Ferguson (FERG)

Share Price is delayed by 15 minutes
Get Live Data
16,990.00    250.00 (1.49%)
Bid:
17,020.00
Ask:
17,050.00
Spread: 30.00 (0.176%)
Market Cap: £32.95b
FERG Live PriceLast checked at - London Stock Exchange

Intraday Ferguson Share Chart

Share repurchase program

19 Dec 2022 07:00

RNS Number : 0650K
Ferguson PLC
19 December 2022
 

December 19, 2022

FERGUSON PLC

Share repurchase program

Ferguson plc (the "Company") announces that, in continuation of its $2.5 billion share repurchase program (the "Program"), it has entered into an irrevocable and non-discretionary arrangement with its broker Barclays Capital Securities Limited and Barclays Capital Inc. (together, "Barclays") commencing from December 19, 2022 and ending no later than January 12, 2023. Under this arrangement, Barclays, an independent third party, will act as principal and will make decisions under the program independently from the Company.

The maximum pecuniary amount allocated to this tranche of the Program is £110 million. The value of shares repurchased by the Company under the Program pursuant to the various arrangements entered into with its brokers will not, in aggregate, exceed US$2,500 million.

The Company's shareholders generally authorized the Company to purchase up to a maximum of 20,845,062 of its ordinary shares at its Annual General Meeting held on November 30, 2022. Pursuant to such authority, the Company intends to continue purchasing shares under the Program. The aggregate number of shares acquired by the Company pursuant to the Program shall not exceed the maximum number of shares which the Company is authorized to purchase pursuant to such general authority. It is intended that any shares repurchased under the Program will be transferred into treasury.

The purpose of the Program is to reduce the capital of the Company. To the extent required, the Company may in future use the repurchased shares to satisfy share awards. Any purchases of shares by the Company in relation to this tranche of the Program will be carried out on the London Stock Exchange and/or the New York Stock Exchange (in accordance with the terms of the arrangement entered into with Barclays) and in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase shares granted by its shareholders, the Market Abuse Regulation 596/2014 (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018), Rule 10b5-1 and Rule 10b-18 under the U.S. Securities Exchange Act of 1934, as amended.

For further information please contact

Ferguson plc

 Brian Lantz, Vice President IR and Communications

Mobile:

+1 224 285 2410

Pete Kennedy, Director of Investor Relations

Mobile:

+1 757 603 0111

 

Media Enquiries

 John Pappas, Director of Financial Communication

Mobile:

+1 484 790 2727

 

 

About Ferguson plc

Ferguson plc (NYSE: FERG; LSE: FERG) is a leading value-added distributor in North America providing expertise, solutions and products from infrastructure, plumbing and appliances to HVAC, fire, fabrication and more. We exist to make our customers' complex projects simple, successful and sustainable. Ferguson is headquartered in the U.K., with its operations and associates solely focused on North America and managed from Newport News, Virginia. For more information, please visit http://www.fergusonplc.com or follow us on LinkedIn https://www.linkedin.com/company/ferguson-enterprises.

Cautionary note regarding forward-looking statements

Certain information in this announcement is forward-looking within the meaning of the United States Private Securities Litigation Reform Act of 1995, including with relation to our share repurchase program and its purpose and timetable. Forward-looking statements cover all matters which are not historical facts and speak only as of the date on which they are made. Forward-looking statements can be identified by the use of forward-looking terminology such as "will," "intend," or other variations or comparable terminology. Many factors could cause actual results to differ materially from those in such forward-looking statements, including, but not limited to: risks associated with the relocation of our primary listing to the US and any volatility in our share price and shareholder base in connection therewith; weakness in the economy, market trends, uncertainty and other conditions in the markets in which we operate, and other factors beyond our control, including any macroeconomic or other consequences of the current conflict in Ukraine; failure to rapidly identify or effectively respond to direct and/or end customers' wants, expectations or trends, including costs and potential problems associated with new or upgraded information technology systems; adverse impacts caused by the COVID-19 pandemic (or related variants); unsuccessful execution of our operational strategies; and the risks and uncertainties set forth in our Form 10-K filed with the Securities and Exchange Commission ("SEC") on September 27, 2022, under the heading "Risk Factors," and in other documents we furnish to or file with the SEC in the future. Forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Other than in accordance with our legal or regulatory obligations we undertake no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBRBDDCBBDGDL
Date   Source Headline
11th Jun 20197:00 amRNSShare buy-back programme
10th Jun 20197:00 amRNSResults for the 3 months ended 30 April 2019
31st May 20192:45 pmRNSTotal Voting Rights
31st May 20191:50 pmRNSDirector/PDMR Shareholding
28th May 20193:30 pmRNSNotice of Results
22nd May 20199:44 amRNSAppointment of Chairman Designate and NED
10th May 20198:30 amRNSAdditional Listing
10th May 20198:01 amRNSAdmission and listing of New Ferguson shares
10th May 20198:00 amRNSScheme of arrangement
8th May 20193:05 pmRNSCourt sanction of scheme of arrangement
7th May 20193:00 pmRNSDirector/PDMR Shareholding
30th Apr 20194:01 pmRNSTotal Voting Rights
29th Apr 20192:05 pmRNSResult of Meeting
29th Apr 201910:55 amRNSDirector/PDMR Shareholding
26th Apr 20192:36 pmRNSPublication of a Prospectus
16th Apr 20199:00 amRNSNotice of Dividend Currency Exchange Rate
4th Apr 20193:28 pmRNSPublication of Circular and Notice of Meetings
29th Mar 20191:01 pmRNSTotal Voting Rights
29th Mar 201912:34 pmRNSDirector/PDMR Shareholding
28th Mar 20193:41 pmRNSDirector Declaration
28th Mar 20199:40 amRNSAdditional Listing
26th Mar 20197:00 amRNSResults for the half year ended 31 January 2019
12th Mar 20192:00 pmRNSNotice of Results
28th Feb 201911:28 amRNSTotal Voting Rights
11th Feb 20198:59 amRNSNon Executive Director Appointment
31st Jan 201911:16 amRNSTotal Voting Rights
23rd Jan 201911:22 amRNSDirector/PDMR Shareholding
31st Dec 201810:30 amRNSTotal Voting Rights
31st Dec 20189:30 amRNSBlock listing Interim Review
14th Dec 20181:34 pmRNSNon-Executive Director Appointment
12th Dec 20183:33 pmRNSDirector/PDMR Shareholding
5th Dec 20182:52 pmRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSQ1 Interim Management Statement
30th Nov 201811:19 amRNSTotal Voting Rights
29th Nov 20181:35 pmRNSResult of AGM
28th Nov 20182:11 pmRNSDirector Declaration
26th Nov 20182:00 pmRNSNotice of Results
23rd Nov 20189:00 amRNSNotice of Dividend Currency Exchange Rate
14th Nov 20182:15 pmRNSDirector/PDMR Shareholding
31st Oct 20183:22 pmRNSTotal Voting Rights
22nd Oct 201811:15 amRNSDirector/PDMR Shareholding
18th Oct 20187:00 amRNSPricing of debut Senior Notes Offering
12th Oct 20187:00 amRNSAnnual Financial Report
2nd Oct 20187:00 amRNSResults for the year ended 31 July 2018
28th Sep 20181:25 pmRNSTotal Voting Rights
18th Sep 201811:30 amRNSNotice of Results
31st Aug 20183:28 pmRNSTotal Voting Rights
31st Jul 20182:12 pmRNSTotal Voting Rights
27th Jul 20189:00 amRNSDirectorate Change
6th Jul 20183:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.